Harmony Biosciences Holdings Inc (NAS:HRMY)
$ 34.2 -0.52 (-1.5%) Market Cap: 1.95 Bil Enterprise Value: 1.75 Bil PE Ratio: 16.21 PB Ratio: 3.27 GF Score: 65/100

Harmony Biosciences Holdings Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 12:30AM GMT
Release Date Price: $47.71 (+0.53%)
Ethan Taylor

Good afternoon, everyone, and welcome to the Harmony Biosciences Company Presentation. My name is Ethan Taylor. I'm the associate in JPMorgan's Healthcare Investment Banking Group. It is my pleasure to introduce Jeffrey Dayno, Interim CEO and Chief Medical Officer. Upon conclusion of Jeffrey's presentation, we will hold a brief Q&A session to discuss topics that are top of mind among investors.

So with that, Jeff, please take it away.

Jeffrey M. Dayno
Harmony Biosciences Holdings, Inc. - Interim CEO, Executive VP & Chief Medical Officer

Thank you, Ethan, for the kind introduction. And I also want to thank JPMorgan for the opportunity to have Harmony share a bit of their story at the conference this year.

Good afternoon, everyone, and thank you for attending this session, especially late on a Wednesday afternoon at JPM to hear a little bit about Harmony Biosciences. So as a reminder, I'll be making forward-looking statements today. Please refer to Harmony's SEC filings and our corporate website for more details.

So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot